| Enhanced brain targeting efficacy of Olanzapine through solid lipid nanoparticles. JA Natarajan J, Baskaran M, Humtsoe LC, Vadivelan R Artificial Cells, Nanomedicine, and Biotechnology: An International Journal, 1-8, 2016 | 64* | 2016 |
| Minutes of PPAR-γ agonism and neuroprotection BRP Kumar, AP Kumar, JA Jose, P Prabitha, S Yuvaraj, S Chipurupalli, ... Neurochemistry International 140, 104814, 2020 | 49 | 2020 |
| Behavioural and neurochemical evaluation of Perment an herbal formulation in chronic unpredictable mild stress induced depressive model. JA Ramanathan M, Balaji B Indian J Exp Biol. 49 (4), 269-275, 2011 | 45* | 2011 |
| Elucidation of neuroprotective role of endogenous GABA and energy metabolites middle cerebral artery occluded model in rats. SS Ramanathan M, Babu CS, Justin A Indian J Exp Biol. 50 (6), 391-397, 2012 | 42* | 2012 |
| Non-hypotensive dose of telmisartan and nimodipine produced synergistic neuroprotective effect in cerebral ischemic model by attenuating brain cytokine levels. RM Justin A, Sathishkumar M, Sudheer A, Shanthakumari S Pharmacology Biochemistry Behavaviour 122, 61-73, 2014 | 35* | 2014 |
| Telmisartan mediates anti-inflammatory and not cognitive function through PPAR-γ agonism via SARM and MyD88 signaling SP Balaji, CV Chand, A Justin, M Ramanathan Pharmacology Biochemistry and Behavior 137, 60-68, 2015 | 33 | 2015 |
| Rational design, synthesis, and in vitro neuroprotective evaluation of novel glitazones for PGC-1α activation via PPAR-γ: a new therapeutic strategy for neurodegenerative disorders A Justin, S Mandal, P Prabitha, S Dhivya, S Yuvaraj, P Kabadi, SJ Sekhar, ... Neurotoxicity research 37, 508-524, 2020 | 25 | 2020 |
| Glitazones, PPAR-γ and neuroprotection AP Kumar, BR Kumar, V Jeyarani, SP Dhanabal, A Justin Mini Reviews in Medicinal Chemistry 21 (12), 1457-1464, 2021 | 20 | 2021 |
| Cerebral ischemia induced inflammatory response and altered glutaminergic function mediated through brain AT1 and not AT2 receptor A Justin, S Divakar, M Ramanathan Biomedicine & Pharmacotherapy 102, 947-958, 2018 | 20 | 2018 |
| Caenorhabditis elegans as a possible model to screen anti-Alzheimer's therapeutics D Paul, S Chipurupalli, A Justin, K Raja, SK Mohankumar Journal of Pharmacological and Toxicological Methods 106, 106932, 2020 | 18 | 2020 |
| Neuroprotective role of Diosgenin, a NGF stimulator, against Aβ (1–42) induced neurotoxicity in animal model of Alzheimer’s disease S Som, J Antony, SP Dhanabal, S Ponnusankar Metabolic Brain Disease, 1-14, 2022 | 15 | 2022 |
| Design, parallel synthesis of Biginelli 1, 4-dihydropyrimidines using PTSA as a catalyst, evaluation of anticancer activity and structure activity relationships via 3D QSAR studies S Faizan, BRP Kumar, NL Naishima, T Ashok, A Justin, MV Kumar, ... Bioorganic Chemistry 117, 105462, 2021 | 15 | 2021 |
| Glitazones Activate PGC-1α Signaling via PPAR-γ: A Promising Strategy for Antiparkinsonism Therapeutics. A Justin, AK TD, M Chinaswamy, BRP Kumar ACS Chemical Neuroscience 12 (13), 2261-2272, 2021 | 14 | 2021 |
| Coumarin-Fatty acid conjugates as potential ERα/AKT-1 Antagonists for ER positive breast cancer J Selvaraj, J John, NM Joghee, J Antony, A Wadhwani, J Natarajan Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2020 | 13 | 2020 |
| Neuronal PET tracers for Alzheimer's disease AP Kumar, N Singh, D Nair, A Justin Biochemical and Biophysical Research Communications 587, 58-62, 2022 | 12 | 2022 |
| Low dose of L-glutamic acid attenuated the neurological dysfunctions and excitotoxicity in bilateral common carotid artery occluded mice M Ramanathan, KK Abdul, A Justin Behavioural Pharmacology 27 (7), 615-622, 2016 | 12 | 2016 |
| Recent Plant Based Remedies for Alzheimer's Disease, Parkinson's Disease and Cerebral Ischemic Stroke P Thomas, S Jeyarani, T Choephel, C Manisha, J Antony Research Journal of Pharmacy and Technology 12 (8), 3951-3959, 2019 | 8 | 2019 |
| In-vitro cell line Models and Assay methods to study the Anti-diabetic Activity J Antony, S Debroy, C Manisha, P Thomas, V Jeyarani, T Choephel Research Journal of Pharmacy and Technology 12 (5), 2200-2206, 2019 | 8 | 2019 |
| Two rationally identified novel glitazones reversed the behavioral dysfunctions and exhibited neuroprotection through ameliorating brain cytokines and oxy-radicals in ICV-LPS … A Justin, P Ashwini, JA Jose, V Jeyarani, SP Dhanabal, C Manisha, ... Frontiers in Neuroscience 14, 530148, 2020 | 7 | 2020 |
| Rational design, molecular docking, dynamic simulation, synthesis, PPAR-γ competitive binding and transcription analysis of novel glitazones AP Kumar, S Mandal, P Prabitha, S Faizan, BRP Kumar, SP Dhanabal, ... Journal of Molecular Structure 1265, 133354, 2022 | 6 | 2022 |
